A new trading day began on Monday, with Immunic Inc (NASDAQ: IMUX) stock price up 5.20% from the previous day of trading, before settling in for the closing price of $0.73. IMUX’s price has ranged from $0.56 to $2.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 26.01% over the past five years. Meanwhile, its annual earnings per share averaged 28.99%. With a float of $92.55 million, this company’s outstanding shares have now reached $95.82 million.
Let’s look at the performance matrix of the company that is accounted for 91 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immunic Inc (IMUX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immunic Inc is 3.42%, while institutional ownership is 40.58%. The most recent insider transaction that took place on Jun 13 ’25, was worth 16,694. In this transaction Executive Chairman of this company bought 20,000 shares at a rate of $0.83, taking the stock ownership to the 36,032 shares. Before that another transaction happened on Jun 05 ’25, when Company’s President and COO bought 12,512 for $0.79, making the entire transaction worth $9,884. This insider now owns 12,512 shares in total.
Immunic Inc (IMUX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 28.99% per share during the next fiscal year.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Here are Immunic Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.98, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Immunic Inc (NASDAQ: IMUX) saw its 5-day average volume 1.05 million, a negative change from its year-to-date volume of 1.27 million. As of the previous 9 days, the stock’s Stochastic %D was 63.27%.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 24.70%, which indicates a significant decrease from 53.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.40% in the past 14 days, which was lower than the 94.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8824, while its 200-day Moving Average is $1.1087. Nevertheless, the first resistance level for the watch stands at $0.7841 in the near term. At $0.8031, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8282. If the price goes on to break the first support level at $0.7400, it is likely to go to the next support level at $0.7149. The third support level lies at $0.6959 if the price breaches the second support level.
Immunic Inc (NASDAQ: IMUX) Key Stats
With a market capitalization of 73.30 million, the company has a total of 95,818K Shares Outstanding. Currently, annual sales are 0 K while annual income is -100,510 K. The company’s previous quarter sales were 0 K while its latest quarter income was -25,470 K.
